3171 results for «223»
3171 results
Mastering LAA closure: a step-by-step case experience
14 Feb 2026 – From PCR Tokyo Valves 2026
This session presents a step-by-step, case-based approach to mastering left atrial appendage (LAA) closure. It covers pre-procedural planning, device-specific strategies, complication prevention, and complex bailout techniques such as leak closure with coiling or dual-device implantation.
Patient-tailored treatment for bicuspid valve
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on patient-tailored treatment for bicuspid aortic valve stenosis, providing comprehensive insights into the evidence base for TAVI in this population. It discusses critical considerations for valve selection and sizing, and highlights anatomical features that may pose challenges for TAVI procedures. Case studies illustrate...
Mitral TEER masterclass
14 Feb 2026 – From PCR Tokyo Valves 2026
This Mitral TEER masterclass focuses on addressing unique anatomical challenges encountered in Asian populations. The session covers device strategies and techniques tailored for complex anatomies, offering practical tips to minimize complications and improve procedural outcomes through detailed case analyses including small hearts, commissural prolapse with calcification,...
Mastering techniques from basic to complex - Advanced TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
Explore advanced TAVI techniques focusing on challenging patient subsets such as those with small annuli, bicuspid valves, and valve-in-valve procedures. This session reviews valve selection and procedural optimization to enhance clinical outcomes in complex scenarios.
TAVI: LIVE Educational Case from Nagoya Heart Center - Nagoya, Japan
15 Feb 2026 – From PCR Tokyo Valves 2026
This live educational case from Nagoya Heart Center provides detailed insights into TAVI procedural optimization, focusing on index valve selection for lifetime management and strategies to address highly calcified, small aortic annuli. Attendees benefit from stepwise procedural demonstrations, operator strategies, imaging analysis, and discussions on facilitating...
Closing Ceremony
15 Feb 2026 – From PCR Tokyo Valves 2026
The Closing Ceremony marked the culmination of the conference, providing a formal conclusion to the event and reflecting on the key advancements and discussions in interventional cardiology presented throughout the sessions.
Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER
13 Feb 2026 – From PCR Tokyo Valves 2026
Delve into mitral regurgitation assessment and the suitability criteria for Transcatheter Edge-to-Edge Repair (TEER). This session reviews mitral valve anatomy, advanced echocardiographic and CT imaging techniques, and the latest clinical data guiding TEER application.
Mastering techniques from basic to complex - Tips and tricks for advanced mitral TEER: anatomy and imaging
13 Feb 2026 – From PCR Tokyo Valves 2026
This session offers advanced insights into mitral TEER, emphasizing anatomical understanding and imaging to improve clinical outcomes. It also addresses device function, procedural steps, and management of common complications to refine interventional skills.
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Author
Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?
09 Jul 2019
An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author